Treatment for life is recommended and there is no proof that relaxation or ceasing treatment is safe during childhood, adolescence or adulthood [54,55,56,57]
The burden of DM is compounded by common comorbidities such as atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD), which affect nearly one-third of individuals with DM [1, 2]
Manuel MSD
I n December 2024, Torrent Pharma acquired three diabetes brands from Boehringer Ingelheim, including those with Empagliflozin, to strengthen its anti-diabetes portfolio In November 2024, AstraZeneca presented promising early data for its obesity pipeline, including AZD5004, an oral GLP-1 receptor blocker, at Obesity Week 2024
How do I adjust my Vitamin B12 injection dosage based on my needs